Literature DB >> 7671255

p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells.

P A Havre1, J Yuan, L Hedrick, K R Cho, P M Glazer.   

Abstract

To study the pathways associated with genomic instability in cancer, we examined UV-induced and spontaneous mutagenesis in clonal cell lines expressing human papillomavirus (HPV) proteins, either high-risk (HPV16) E6 or E7 or low-risk (HPV11) E6, in comparison to the parental RKO cells, a colon carcinoma cell line expressing only normal p53. High-risk E6 and E7 bind and functionally inactivate tumor suppressor proteins p53 and Rb, respectively, and both disrupt the G1 arrest in response to DNA damage. Low-risk HPV E6 proteins bind p53 with much lower affinity than high-risk E6 and fail to mediate p53 degradation or to disrupt the G1 checkpoint. We found that cells expressing HPV16 E6 had reduced survival and increased mutagenesis at the hprt locus when treated with low doses of UV. However, this analysis was complicated by the unexpected observation of a very high background of spontaneous mutagenesis in the unirradiated cells expressing the HPV16 E6 gene. Fluctuation analysis revealed a 5-fold elevated mutation rate in the cells expressing HPV16 E6. HPV11 E6 conferred a 2-fold elevation in the mutation rate, but HPV16 E7 had no effect. The increased spontaneous mutagenesis, therefore, appeared to be mediated by p53 inactivation and to be independent of Rb (which acts downstream of p53 in the G1 arrest pathway following DNA damage). Taken together, these findings suggest that the effect of p53 inactivation on spontaneous mutagenesis is manifested at the level of DNA repair, recombination, or coupling of transcription with one of these processes instead of by an alteration in G1 arrest.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7671255

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

1.  Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase alpha-primase.

Authors:  Christian Melle; Heinz-Peter Nasheuer
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

Review 3.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

Review 4.  The two faces of tumor suppressor p53.

Authors:  M L Smith; A J Fornace
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

Review 5.  p53-mediated protective responses to UV irradiation.

Authors:  M L Smith; A J Fornace
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

6.  Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation.

Authors:  C G Maki; P M Howley
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

7.  Triple-helix formation induces recombination in mammalian cells via a nucleotide excision repair-dependent pathway.

Authors:  A F Faruqi; H J Datta; D Carroll; M M Seidman; P M Glazer
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

8.  Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers.

Authors:  Gabriele Galliverti; Stephan Wullschleger; Mélanie Tichet; Dhaarini Murugan; Nadine Zangger; Wesley Horton; Alan J Korman; Lisa M Coussens; Melody A Swartz; Douglas Hanahan
Journal:  Cancer Immunol Res       Date:  2019-11-26       Impact factor: 11.151

9.  Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality.

Authors:  S Solinas-Toldo; M Dürst; P Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

10.  Early p53 mutations in nondysplastic Barrett's tissue detected by the restriction site mutation (RSM) methodology.

Authors:  G J S Jenkins; S H Doak; A P Griffiths; N Tofazzal; V Shah; J N Baxter; J M Parry
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.